Introduction
Parry-Romberg syndrome (PRS) is characterized by progressive dystrophy
or loss of subcutaneous tissue in one half of the face, usually
beginning in childhood and often continuing with skin changes1. This atrophy affects
the subcutaneous tissue, fat, muscle and bone-cartilaginous structures
and creates a sunken appearance in the face2. This syndrome is
often associated with linear scleroderma and is also known as En coup de
sabre 3. The clinical
feature of PRS that makes it possible to diagnose is unilateral
idiopathic facial atrophy4. This disease is
self-limiting and its treatment is multidisciplinary5. Treatment is usually
based on the replacement of adipose tissue that has been lost due to
atrophy 6. Surgical
treatment for PRS often requires a multispecialty approach with repeated
procedures, depending on the extent of involvement7. The goal of surgical
treatment for PRS patients is to minimize the psychosocial effects and
correct the appearance and function of the involved facial structures5.